1. Hypoxia induces the expression of TET enzymes in HepG2 cells
   Guofu Lin et al, 2017, Oncology Letters CrossRef
2. Association between long interspersed nuclear element-1 methylation levels and relapse in Wilms tumors
   Bruna M. de Sá Pereira et al, 2017, Clinical Epigenetics CrossRef
3. Epigenetics and genetics of hepatoblastoma: Linkage and treatment
   Li-ran Zhu et al, 2022, Frontiers in Genetics CrossRef
4. Hepatoblastoma—The Evolution of Biology, Surgery, and Transplantation
   Irene Lim et al, 2018, Children CrossRef
5. TET Upregulation Leads to 5-Hydroxymethylation Enrichment in Hepatoblastoma
   Maria Prates Rivas et al, 2019, Frontiers in Genetics CrossRef
6. Epigenetic remodelling in human hepatocellular carcinoma
   Maria Rita Braghini et al, 2022, Journal of Experimental & Clinical Cancer Research CrossRef
7. DNA methylation landscape of hepatoblastomas reveals arrest at early stages of liver differentiation and cancer-related alterations
   Mariana Maschietto et al, 2017, Oncotarget CrossRef
8. Liver and Pancreas
   Sarangarajan Ranganathan, 2018, Precision Molecular Pathology of Neoplastic Pediatric Diseases CrossRef
9. DNA methylation in Hepatoblastoma-a literature review
   Gang Shen et al, 2020, Italian Journal of Pediatrics CrossRef
10. Emergence of the Dedifferentiated Phenotype in Hepatocyte‐Derived Tumors in Mice: Roles of Oncogene‐Induced Epigenetic Alterations
    Kenji Watanabe et al, 2019, Hepatology Communications CrossRef
11. Potential methylation-regulated genes and pathways in hepatocellular neoplasm, not otherwise specified
    Shengmei Zhou et al, 2022, Frontiers in Oncology CrossRef
12. Hepatoblastomas exhibit markedNNMTdownregulation driven by promoter DNA hypermethylation
    Maria Prates Rivas et al, 2020, Tumor Biology CrossRef
13. Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications
    Juan Carrillo-Reixach et al, 2020, Journal of Hepatology CrossRef
14. Oncogenic Role of ADAM32 in Hepatoblastoma: A Potential Molecular Target for Therapy
    Takahiro Fukazawa et al, 2022, Cancers CrossRef
15. ARID1B/SUB1‐activated lncRNA HOXA‐AS2 drives the malignant behaviour of hepatoblastoma through regulation of HOXA3
    Gongbao Liu et al, 2021, Journal of Cellular and Molecular Medicine CrossRef
16. Identification and experimental validation of druggable epigenetic targets in hepatoblastoma
    Alex Clavería-Cabello et al, 2023, Journal of Hepatology CrossRef
17. Integrative Analysis of DNA Methylation and Gene Expression Profiling Data Reveals Candidate Methylation-Regulated Genes in Hepatoblastoma
    Jian-Yao Wang et al, 2021, International Journal of General Medicine CrossRef